Published in Hepatology on August 01, 2001
Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg (2003) 3.16
Preoperative portal vein embolization for extended hepatectomy. Ann Surg (2003) 2.33
ALPPS for patients with colorectal liver metastases: effective liver hypertrophy, but early tumor recurrence. World J Surg (2014) 1.66
Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg (2007) 1.58
Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. World J Surg (2007) 1.52
Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol (2012) 1.50
Preoperative portal vein embolization in liver cancer: indications, techniques and outcomes. Quant Imaging Med Surg (2015) 1.42
Current treatment for colorectal liver metastases. World J Gastroenterol (2011) 1.38
Current treatment for liver metastases from colorectal cancer. World J Gastroenterol (2003) 1.28
How to avoid postoperative liver failure: a novel method. World J Surg (2012) 1.14
Effect of portal vein embolisation on the growth rate of colorectal liver metastases. Br J Cancer (2009) 1.10
Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases. HPB (Oxford) (2012) 1.01
The surgical treatment of hepatic metastases in colorectal carcinoma. Dtsch Arztebl Int (2010) 0.95
Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases. Int J Colorectal Dis (2008) 0.93
Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: a review. World J Gastroenterol (2015) 0.91
Feasibility of laparoscopic portal vein ligation prior to major hepatectomy. HPB (Oxford) (2008) 0.89
Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate. Ann Surg (2006) 0.88
Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections. World J Surg Oncol (2009) 0.87
Portal vein embolization before major hepatectomy. World J Gastroenterol (2005) 0.87
Hypertrophy of the non-embolized liver after chemotherapy. HPB (Oxford) (2009) 0.86
ALPPS Procedure for Extended Liver Resections: A Single Centre Experience and a Systematic Review. PLoS One (2015) 0.86
Preoperative portal vein embolization for hepatocellular carcinoma: Consensus and controversy. World J Hepatol (2016) 0.84
Tumour progression and liver regeneration--insights from animal models. Nat Rev Gastroenterol Hepatol (2013) 0.84
Impact of the degree of liver resection on survival for patients with multiple liver metastases from colorectal cancer. World J Surg (2008) 0.83
Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases. HPB (Oxford) (2015) 0.82
One-stage hepatectomy following portal vein embolization for colorectal liver metastasis. World J Surg (2013) 0.82
Portal vein ligation accelerates tumor growth in ligated, but not contralateral lobes. World J Gastroenterol (2010) 0.82
The liver prometastatic reaction of cancer patients: implications for microenvironment-dependent colon cancer gene regulation. Cancer Microenviron (2011) 0.81
Prognostic importance of some clinical and therapeutic factors for the effect of portal vein embolization in patients with primarily inoperable colorectal liver metastases. Arch Med Sci (2013) 0.81
Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation. World J Gastroenterol (2012) 0.80
Treatment for multiple bilobar liver metastases of colorectal cancer. Langenbecks Arch Surg (2005) 0.80
Portal vein embolization and ligation for extended hepatectomy. Indian J Surg Oncol (2014) 0.80
An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence. Medicine (Baltimore) (2016) 0.80
Current state of surgical treatment of liver metastases from colorectal cancer. World J Gastrointest Surg (2011) 0.80
Multimodal treatment options for bilobar colorectal liver metastases. Langenbecks Arch Surg (2010) 0.80
Is there new hope for patients with marginally resectable liver malignancies. World J Gastrointest Surg (2012) 0.79
Timing of two-stage liver resection during chemotherapy for otherwise unresectable colorectal metastases. World J Surg (2012) 0.79
Preoperative embolization. Semin Intervent Radiol (2004) 0.78
Effect of portal vein ligation on tumor growth and liver regeneration in rat cirrhotic liver lobes. Exp Ther Med (2014) 0.78
Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment. Int J Colorectal Dis (2012) 0.78
Role of surgery in colorectal liver metastases: too early or too late? World J Gastroenterol (2010) 0.78
Associated Liver Partition and Portal Vein Ligation (ALPPS) vs Selective Portal Vein Ligation (PVL) for Staged Hepatectomy in a Rat Model. Similar Regenerative Response? PLoS One (2015) 0.78
Portal vein embolization effect on colorectal cancer liver metastasis progression: Lessons learned. World J Clin Oncol (2015) 0.76
Can plasma bile salt, triglycerides, and apoA-V levels predict liver regeneration? World J Surg (2012) 0.76
Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignancies. HPB (Oxford) (2012) 0.76
Staged resection of bilobar colorectal liver metastases: surgical strategies. Langenbecks Arch Surg (2015) 0.76
ALPPS Procedure in Insufficient Hypertrophy After Portal Vein Embolization (PVE). World J Surg (2017) 0.76
Tumour growth of colorectal rat liver metastases is inhibited by hepatic arterial infusion of the mTOR-inhibitor temsirolimus after portal branch ligation. Clin Exp Metastasis (2015) 0.76
Chronological changes in the liver after temporary partial portal venous occlusion. World J Gastroenterol (2013) 0.75
Portal Vein Embolization: Impact of Chemotherapy and Genetic Mutations. J Clin Med (2017) 0.75
Mechanistic insights of rapid liver regeneration after associating liver partition and portal vein ligation for stage hepatectomy. World J Gastroenterol (2016) 0.75
Liver Injury and Tumor-Inhibiting Effect of Sequential Transcatheter Arterial Chemoembolization and Portal Venous Embolization on Rabbit VX2 Liver Carcinoma. Med Sci Monit (2017) 0.75
Portal vein embolization for induction of selective hepatic hypertrophy prior to major hepatectomy: rationale, techniques, outcomes and future directions. Cancer Biol Med (2016) 0.75
The role of (90)Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review. Clin Transl Imaging (2016) 0.75
More than 7-year survival of a patient following repeat hepatectomy for total 20 colon cancer liver metastases. J Korean Surg Soc (2012) 0.75
Strategies for resection using portal vein embolization: metastatic liver cancer. Semin Intervent Radiol (2008) 0.75
Mortality after portal vein embolization: Two case reports. Medicine (Baltimore) (2017) 0.75
Two-stage hepatectomy and associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) in treating liver metastases of rectal cancer: a case report. Springerplus (2015) 0.75
Parenchyma-Sparing Hepatectomy with Vascular Reconstruction Techniques for Resection of Colorectal Liver Metastases with Major Vascular Invasion. Ann Surg Oncol (2016) 0.75
Strategies to increase the resectability of hepatocellular carcinoma. World J Hepatol (2015) 0.75
Demonstration of metabolic and cellular effects of portal vein ligation using multi-modal PET/MRI measurements in healthy rat liver. PLoS One (2014) 0.75
Hobson's choice two-stage hepatectomy for multiple and bilobar colorectal liver metastases with portal vein embolization: report of two cases. Surg Today (2014) 0.75
Next generation sequencing of progressive colorectal liver metastases after portal vein embolization. Clin Exp Metastasis (2017) 0.75
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res (1999) 11.32
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell (1993) 9.06
Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol (1999) 8.98
Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase. Biochem Biophys Res Commun (1986) 7.96
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev (2001) 7.60
Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet (1997) 7.59
Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells. J Exp Med (1975) 7.20
A thin slice preparation for patch clamp recordings from neurones of the mammalian central nervous system. Pflugers Arch (1989) 6.98
LDL-receptor-related proteins in Wnt signal transduction. Nature (2000) 6.94
Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A (1976) 6.82
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J (1999) 6.62
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A (2000) 6.59
Patch clamp measurements on Xenopus laevis oocytes: currents through endogenous channels and implanted acetylcholine receptor and sodium channels. Pflugers Arch (1986) 6.15
The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr (1994) 5.47
Pharmacokinetic interactions related to the chemical structures of fluoroquinolones. J Antimicrob Chemother (1996) 5.34
ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep (2001) 5.32
Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest (1999) 5.30
Surface alloantigens of plasma cells. J Exp Med (1970) 5.19
Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. J Exp Med (1976) 5.05
Identification of CRE1 as a cytokinin receptor from Arabidopsis. Nature (2001) 4.77
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature (2000) 4.66
Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun (1989) 4.63
Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer (2000) 4.55
Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature (1986) 4.30
Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1. Cell (2001) 4.22
Serological analysis of cell surface antigens of malignant human brain tumors. Proc Natl Acad Sci U S A (1978) 3.99
Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer (1998) 3.98
Regulation of drought tolerance by gene manipulation of 9-cis-epoxycarotenoid dioxygenase, a key enzyme in abscisic acid biosynthesis in Arabidopsis. Plant J (2001) 3.92
Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res (1998) 3.79
Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity (1996) 3.66
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain (2007) 3.64
Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-beta-lactamase gene blaIMP. Antimicrob Agents Chemother (1998) 3.57
Immunoglobulin and other surface antigens of cells of the immune system. J Exp Med (1971) 3.50
Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med (1979) 3.43
Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics. J Exp Med (1977) 3.42
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res (1998) 3.20
Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene (2007) 3.11
CBP as a transcriptional coactivator of c-Myb. Genes Dev (1996) 3.09
Numbers, time and neocortical neuronogenesis: a general developmental and evolutionary model. Trends Neurosci (1995) 3.08
Safe right subclavian vein puncture: the importance of pressing the skin with the left thumb. Am J Emerg Med (1993) 3.07
Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol (1999) 3.02
Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. J Biol Chem (1999) 2.99
Complete genome sequence of an aerobic thermoacidophilic crenarchaeon, Sulfolobus tokodaii strain7. DNA Res (2001) 2.99
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene (1990) 2.97
Expression of functional sodium channels from cloned cDNA. Nature (1986) 2.95
Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J (1995) 2.87
Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat Genet (2001) 2.79
Observational contrains on the global atmospheric co2 budget. Science (1990) 2.76
Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell (2000) 2.70
Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity (1995) 2.70
Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis (1993) 2.69
beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation. Proc Natl Acad Sci U S A (1999) 2.66
Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy. Neurology (2002) 2.66
NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J Exp Med (1997) 2.66
Toxocariasis possibly caused by ingesting raw chicken. J Infect Dis (1989) 2.64
Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron (1996) 2.62
A transmembrane hybrid-type histidine kinase in Arabidopsis functions as an osmosensor. Plant Cell (1999) 2.62
Detection of antibody to autologous human leukemia cells by immune adherence assays. Proc Natl Acad Sci U S A (1977) 2.59
Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med (1992) 2.59
Inactivation of presynaptic calcium current contributes to synaptic depression at a fast central synapse. Neuron (1998) 2.56
Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J Biol Chem (1992) 2.55
Microsatellite instability in acute myelocytic leukaemia developed from A-bomb survivors. Int J Radiat Biol (2001) 2.54
Molecular chaperones in the yeast endoplasmic reticulum maintain the solubility of proteins for retrotranslocation and degradation. J Cell Biol (2001) 2.53
Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci U S A (1999) 2.53
Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J Exp Med (1982) 2.52
Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes. J Exp Med (1983) 2.49
Rabphilin-3A, a putative target protein for smg p25A/rab3A p25 small GTP-binding protein related to synaptotagmin. Mol Cell Biol (1993) 2.48
PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J (1998) 2.44
Expression of functional acetylcholine receptor from cloned cDNAs. Nature (1984) 2.41
Rat brain serotonin receptors in Xenopus oocytes are coupled by intracellular calcium to endogenous channels. Proc Natl Acad Sci U S A (1987) 2.41
Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells. Br J Cancer (2005) 2.37
Non-NMDA glutamate receptor occupancy and open probability at a rat cerebellar synapse with single and multiple release sites. J Physiol (1996) 2.34
Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study. Neurology (2010) 2.24
Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun (2001) 2.24
Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol (2000) 2.24
Collective review of small carcinomas of the pancreas. Ann Surg (1986) 2.24
Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature (1997) 2.20
Deficiency of protein C in patients with portal vein thrombosis. Hepatology (1988) 2.19
Evaluation of topical pharyngeal anesthesia for upper endoscopy including factors associated with patient tolerance. Gastrointest Endosc (2001) 2.19
The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3. Nature (1998) 2.18
An Arabidopsis gene family encoding DRE/CRT binding proteins involved in low-temperature-responsive gene expression. Biochem Biophys Res Commun (1998) 2.18
Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man. J Clin Invest (1971) 2.15
Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet (1995) 2.15
Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase. J Biol Chem (2000) 2.15
Age-related changes in cell surface antigens of preleukemic AKR thymocytes. J Exp Med (1976) 2.15
Two cases of torsion of the gallbladder diagnosed preoperatively. J Pediatr Surg (1997) 2.14
Identification of endo-beta-N-acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase as cluster-dispersing enzymes in Staphylococcus aureus. J Bacteriol (1995) 2.13
Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res (1993) 2.12
Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J Exp Med (1982) 2.11
Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res (1997) 2.11
Phylogenetic analysis of the entire genome of influenza A (H3N2) viruses from Japan: evidence for genetic reassortment of the six internal genes. J Virol (1998) 2.11
Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Res (1992) 2.09
Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development (1993) 2.09
Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem (1994) 2.09
Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet (1992) 2.07